Pet Nutraceuticals Market Poised for Major Growth: $8.84 Billion by 2031

Dublin, Jan. 21, 2026 (GLOBE NEWSWIRE) -- The "Pet Nutraceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The report is segmented by sub-product categories, pet types, distribution channels, and regions. The pet nutraceuticals market is poised for substantial growth, with its size projected to reach USD 6.26 billion by 2026, an increase from USD 5.84 billion in 2025. Looking further ahead, projections for 2031 estimate a market value of USD 8.84 billion, growing at a CAGR of 7.15% during 2026-2031. Strong market expansion is driven by the ongoing trend of pet humanization, increasing veterinary support for functional ingredients, and the growing consumer inclination to prioritize preventive pet care as an essential expenditure. Notably, there is heightened demand for premium products targeting joint mobility, weight management, cognitive health, and digestive balance. This demand is propelled by ingredient innovations, such as algae-based omega-3 oils, and the rise of digital subscription models that promote dosing compliance. The competitive landscape remains moderate, with established pet food companies expanding their wellness offerings and niche supplement producers accelerating product development cycles. Humanization of Pets Drives Functional Nutrition Demand Pet owners increasingly treat their pets following human health paradigms, prompting demand for nutraceuticals that align with human dietary trends. This shift is evident as 41% of U.S. consumers purchased pet supplements in 2022. The humanization trend extends into targeted wellness solutions, covering joint mobility, cognitive function, and digestive health. The premium product positioning emerges less price-sensitive when considered as preventive healthcare rather than optional treats. Millennials and Gen Z consumers, approaching peak pet ownership years with higher disposable incomes, demonstrate a willingness to invest in pet wellness. Rising Incidence of Pet Obesity and Chronic Diseases The growing prevalence of obesity-related conditions among pets has spurred demand for nutraceuticals focused on weight management and metabolic health. According to the Association for Pet Obesity Prevention, over 50% of dogs and cats in developed markets are overweight or obese, leading to increased veterinary recommendations for metabolic-supporting supplements. Furthermore, chronic conditions such as arthritis, diabetes, and digestive disorders highlight the necessity for nutraceuticals, positioning them as complementary to pharmaceutical interventions and enabling premium pricing models and repeat purchases. Fragmented Regulatory Definitions Across Regions The lack of uniform global standards for classifying pet nutraceuticals poses compliance challenges that hinder multi-region product launches and elevate regulatory costs. While the FDA's recent guidance seeks to clarify distinctions between pet foods and drugs, significant gaps remain in defining functional ingredients and health claims. The European Food Safety Authority (EFSA) and various Asia-Pacific markets have distinct frameworks that require separate regulatory submissions, impacting smaller companies and limiting innovation. Other drivers and restraints analyzed in the detailed report include: Premiumization Elevates Spend on Wellness Products Tele-Veterinary Platforms Push Nutraceutical Subscriptions Premium Pricing Limits Uptake in Developing Markets Segment Analysis Vitamins and minerals dominate the pet nutraceuticals market, accounting for 26.35% of the market size in 2025, due to their established safety profiles and broad acceptance across multiple health applications. This segment, benefiting from decades of human nutritional research, shows the fastest growth at a 7.90% CAGR through 2031. Geography Analysis North America leads the global market, with a 44.10% share in 2025, supported by high pet ownership rates and advanced regulatory frameworks. Europe holds a significant share, driven by regulatory leadership and sustainability trends. In Africa, the highest growth rate of 8.75% CAGR through 2031 reflects early-stage market development and increased awareness of nutritional health benefits. Key Topics Covered 1 INTRODUCTION 1.1 Study Assumptions and Market Definition 1.2 Scope of the Study 1.3 Research Methodology 2 REPORT OFFERS 3 EXECUTIVE SUMMARY AND KEY FINDINGS 4 KEY INDUSTRY TRENDS 4.1 Pet Population 4.2 Pet Expenditure 4.3 Consumer Trends 5 SUPPLY AND PRODUCTION DYNAMICS 5.1 Trade Analysis 5.2 Ingredient Trends 5.3 Value Chain & Distribution Channel Analysis 5.4 Regulatory Framework 5.5 Market Drivers 5.6 Market Restraints 6 MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME) 6.1 Sub Product 6.2 Pets 6.3 Distribution Channel 6.4 Region 7 COMPETITIVE LANDSCAPE 7.1 Key Strategic Moves 7.2 Market Share Analysis 7.3 Brand Positioning Matrix 7.4 Market Claim Analysis 7.5 Company Landscape 7.6 Company Profiles 8 KEY STRATEGIC QUESTIONS FOR PET FOOD CEOS A selection of companies mentioned in this report includes, but is not limited to: Mars, Incorporated Vetoquinol ADM Clearlake Capital Group, L.P. (Wellness Pet Company, Inc.) Nestle (Purina) Virbac Alltech Vafo Praha s.r.o. Nutramax Laboratories, Inc. Dechra Pharmaceuticals PLC Zesty Paws LLC Blue Buffalo (General Mills Inc.) Kemin Industries, Inc. DSM-Firmenich Healthy Pets Inc. For more information about this report visit https://www.researchandmarkets.com/r/1b0tts About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.